Physician profile
Anthony Burgos
NPI 1376702258
$440.19
in general payments reported to CMS, 2019-2025
10 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $24.15 · 2024: $174 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $161.52 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sirtex Medical INC | $48.30 | 2019-2020 | |
| Stryker Corporation | $38.28 | 2025 | Clottriever Bold Catheter, Inthrill Thrombectomy Catheter |
| Becton, Dickinson and Company | $37.90 | 2024 | Lifestream |
| Imperative Care, INC | $33.05 | 2025 | Symphony Catheter |
| Boston Scientific Corporation | $29.76 | 2019 | |
| Covidien Lp | $29.08 | 2019 | |
| Trisalus Life Sciences, INC. | $26.78 | 2025 | Trinav Infusion System |
| Medtronic Minimed, INC. | $17.87 | 2019 | |
| Cook Medical LLC | $17.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Burgos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.